×
GeneDx Holdings Price to Free Cash Flow Ratio 2020-2024 | WGS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GeneDx Holdings price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as
View More
GeneDx Holdings Price to Free Cash Flow Ratio 2020-2024 | WGS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GeneDx Holdings price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$120.6B
Cencora (COR)
$44.1B
ICON (ICLR)
$23.6B
DiDi Global (DIDIY)
$22.4B
Avantor (AVTR)
$17.7B
Revvity (RVTY)
$15.6B
Natera (NTRA)
$15.3B
Viatris (VTRS)
$13.9B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$11.8B
Charles River Laboratories (CRL)
$10.2B
Medpace Holdings (MEDP)
$10.1B
Sonic Healthcare (SKHHY)
$9.1B
Doximity (DOCS)
$7.9B
HealthEquity (HQY)
$6.9B
Bausch + Lomb (BLCO)
$6.7B
PACS (PACS)
$6B
Organon (OGN)
$4.9B
Life Times (LTH)
$4.9B
Sotera Health (SHC)
$4.7B
Surgery Partners (SGRY)
$4.1B
Concentras Parent (CON)
$2.9B
Ardent Health Partners (ARDT)
$2.7B
GoodRx Holdings (GDRX)
$2.5B
BrightSpring Health Services (BTSG)
$2.5B
Alignment Healthcare (ALHC)
$2.1B
Premier (PINC)
$2B
Ryman Healthcare (RYHTY)
$2B
AMN Healthcare Services Inc (AMN)
$1.6B
CareDx (CDNA)
$1.6B